author-photo

Kirsten A. Nagashima

12

Papers

4687

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Protection Against Clostridium difficile Infection With Broadly Neutralizing Antitoxin Monoclonal Antibodies

2012 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (66)
Multiple CCR5 Conformations on the Cell Surface Are Used Differentially by Human Immunodeficiency Viruses Resistant or Sensitive to CCR5 Inhibitors

2011 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (52)
Anticorps pour le traitement d'une infection et d'une maladie associées à clostridium difficile

2011
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of advanced human immunodeficiency virus type 1 disease with the viral entry inhibitor PRO 542.

2004 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (120)
Human Immunodeficiency Virus Type 1 Entry Inhibitors PRO 542 and T-20 Are Potently Synergistic in Blocking Virus-Cell and Cell-Cell Fusion

2001 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (102)
Differential Inhibition of Human Immunodeficiency Virus Type 1 Fusion, gp120 Binding, and CC-Chemokine Activity by Monoclonal Antibodies to CCR5

1999 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (208)
Amino-Terminal Substitutions in the CCR5 Coreceptor Impair gp120 Binding and Human Immunodeficiency Virus Type 1 Entry

1998 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (207)
Human immunodeficiency virus type 1 membrane fusion mediated by a laboratory-adapted strain and a primary isolate analyzed by resonance energy transfer.

1996 Journal of Virology
Show All
- Source
- Cite
- Save
Citations (23)
HIV-1 entry into CD4 + cells is mediated by the chemokine receptor CC-CKR-5

1996 Nature
Show All
- Source
- Cite
- Save
Citations (2999)